Literature DB >> 26891195

Patient and Provider-Identified Factors Contributing to Surgical Readmission After Colorectal Surgery.

Tori Sutherland1, Jo Ann David-Kasdan2, Jennifer Beloff2, Ariel Mueller1, Edward E Whang3, Ronald Bleday3, Richard D Urman4.   

Abstract

PURPOSE: Nearly one in seven surgical patients is readmitted to the hospital within 30 days of discharge. Few studies have identified patient-centric factors that raise the risk of both preventable and nonpreventable postoperative readmissions.
MATERIALS AND METHODS: Over 6 months in 2012, 48 colorectal surgical patients were identified on re-admission within 30 days of discharge. We prospectively obtained information on the patient's and primary surgeon's views on factors that contributed to readmission, and compiled data to produce an external list of contributing factors. A standard cost analysis was performed.
RESULTS: 48 colorectal surgery patients participated, and 47 were included in this patient-centric evaluation of factors leading to readmission. The three primary readmission diagnoses included dehydration, fever, and ileus or small bowel obstruction. Of all readmissions, 23% were considered to be preventable. 38% of patients had scheduled follow-up appointments that were documented in the medical record at the time of discharge. Providers identified several factors contributing to readmission including difficulty understanding discharge plan, medication management and premature discharge. Per patient, the cost of preventable readmission was $15,366 (±20%; $12,293-$18,439). Total preventable cost was $169,025 (±20%; $135,220-$202,829).
CONCLUSIONS: The ability to obtain an outpatient postoperative appointment and the understanding of their own postoperative care were the most commonly identified barriers. Interventions to help reduce unnecessary readmissions include a standard discharge process and coordinator, and routine (<7 days) postdischarge outpatient appointments. Successful reduction of preventable readmissions would result in approximately $3.6 million in cost savings per 1,000 colorectal readmissions.

Entities:  

Keywords:  colorectal surgery; complication; patient-centric analysis; postoperative; readmission; reasons

Mesh:

Year:  2016        PMID: 26891195     DOI: 10.3109/08941939.2015.1124947

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  6 in total

1.  Readmissions after colorectal surgery: not all are equal.

Authors:  Laura Z Hyde; Ahmed M Al-Mazrou; Ben A Kuritzkes; Kunal Suradkar; Neda Valizadeh; Ravi P Kiran
Journal:  Int J Colorectal Dis       Date:  2018-08-30       Impact factor: 2.571

2.  Effectiveness of care transition strategies for colorectal cancer patients: a systematic review and meta-analysis.

Authors:  Letícia Flores Trindade; Julia Estela Willrich Boell; Elisiane Lorenzini; Wilson Cañon Montañez; Michelle Malkiewiez; Edith Pituskin; Adriane Cristina Bernat Kolankiewicz
Journal:  Support Care Cancer       Date:  2022-04-22       Impact factor: 3.359

3.  Readmission After Elective Ileostomy in Colorectal Surgery Is Predictable.

Authors:  Atif Iqbal; Ilya Sakharuk; Lindsey Goldstein; Sanda A Tan; Peihua Qiu; Zhaomian Li; Steven J Hughes
Journal:  JSLS       Date:  2018 Jul-Sep       Impact factor: 2.172

4.  Patients' and providers' perspectives on medication relatedness and potential preventability of hospital readmissions within 30 days of discharge.

Authors:  Elien B Uitvlugt; Marjo J A Janssen; Carl E H Siegert; Anna J A Leenders; Bart J F van den Bemt; Patricia M L A van den Bemt; Fatma Karapinar-Çarkit
Journal:  Health Expect       Date:  2019-11-16       Impact factor: 3.377

5.  Towards a patient journey perspective on causes of unplanned readmissions using a classification framework: results of a systematic review with narrative synthesis.

Authors:  R G Singotani; F Karapinar; C Brouwers; C Wagner; M C de Bruijne
Journal:  BMC Med Res Methodol       Date:  2019-10-04       Impact factor: 4.615

6.  Preventability of unplanned readmissions within 30 days of discharge. A cross-sectional, single-center study.

Authors:  Albertine M B van der Does; Eva L Kneepkens; Elien B Uitvlugt; Sanne L Jansen; Louise Schilder; George Tokmaji; Sofieke C Wijers; Marijn Radersma; J Nina M Heijnen; Paul F A Teunissen; Pim B J E Hulshof; Geke M Overvliet; Carl E H Siegert; Fatma Karapinar-Çarkit
Journal:  PLoS One       Date:  2020-04-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.